PROCEPT BioRobotics Corporation (PRCT) Earnings History
Net Loss7 years of earnings data (2019–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
PROCEPT BioRobotics Corporation (PRCT) Earnings Overview
As of July 8, 2026, PROCEPT BioRobotics Corporation (PRCT) reported trailing twelve-month net income of -$102M, reflecting +1.7% year-over-year growth. The company earned $-1.81 per diluted share over the past four quarters, with a net profit margin of -31.0%.
Looking at the long-term picture, PRCT's historical earnings data spans multiple years. The company achieved its highest annual net income of -$42M in fiscal 2019.
PROCEPT BioRobotics Corporation is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ISRG ($2.98B net income, 28.4% margin), NVCR (-$173M net income, -20.8% margin), NTRA (-$226M net income, -9.0% margin), PRCT has room to improve margins relative to the peer group. Compare PRCT vs ISRG →
PRCT Earnings vs Peers
Earnings metrics vs comparable public companies
PRCT Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$96M | -4.5% | -$104M | $-1.72 | -31.0% | -33.7% |
| 2024 | -$91M | +13.7% | -$97M | $-1.75 | -40.7% | -43.0% |
| 2023 | -$106M | -21.5% | -$109M | $-2.24 | -77.8% | -80.2% |
| 2022 | -$87M | -45.6% | -$81M | $-1.96 | -116.2% | -107.6% |
| 2021 | -$60M | -12.9% | -$54M | $-1.37 | -173.6% | -157.1% |
| 2020 | -$53M | -26.3% | -$48M | $-1.51 | -687.0% | -619.4% |
| 2019 | -$42M | - | -$44M | $-1.25 | -680.4% | -705.9% |
Download Data
Export PRCT earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PRCT — Frequently Asked Questions
Quick answers to the most common questions about buying PRCT stock.
What is PRCT earnings per share (EPS)?
PRCT trailing twelve-month (TTM) diluted EPS is $-1.81, reflecting +1.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is PROCEPT BioRobotics Corporation's net income?
PROCEPT BioRobotics Corporation (PRCT) trailing twelve-month net income is $-102M as of 2025. Earnings grew +1.7% year-over-year.
Is PRCT profitable?
PRCT is not currently profitable on a TTM basis, reporting a net loss of $-102M. Net margin is -31.0%. Investors should monitor for a return to profitability.
What is PRCT's earnings growth rate?
PRCT compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are PRCT's profit margins?
PROCEPT BioRobotics Corporation net profit margin is -31.0%, operating margin is -33.7%, and gross margin is +63.7%. Below-average margins reflect competitive or cost pressures. Return on Equity is -24.9%.
Is PRCT growing earnings?
PRCT earnings growth is slowing. Current YoY EPS growth of +1.7% trails the 5-year CAGR of N/A. TTM net income is $-102M.
What was PRCT's best earnings year?
PROCEPT BioRobotics Corporation's highest annual net income on record is $-42M, achieved in fiscal year 2019. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were PRCT's earnings last quarter?
PRCT's most recent reported quarter was Q1 2026. Net income was $-32M with diluted EPS of $-0.56. For a full breakdown of all quarters, see the quarterly earnings table on this page.